ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 123 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $224,000 | +0.9% | 4,874 | -2.5% | 0.00% | 0.0% |
Q3 2018 | $222,000 | +31.4% | 4,999 | +16.1% | 0.00% | +50.0% |
Q2 2018 | $169,000 | -45.7% | 4,304 | 0.0% | 0.00% | -60.0% |
Q1 2018 | $311,000 | +6.5% | 4,304 | -2.9% | 0.01% | +25.0% |
Q4 2017 | $292,000 | +16.3% | 4,433 | -11.6% | 0.00% | 0.0% |
Q3 2017 | $251,000 | +27.4% | 5,012 | +18.0% | 0.00% | +33.3% |
Q2 2017 | $197,000 | +21.6% | 4,247 | -7.7% | 0.00% | 0.0% |
Q1 2017 | $162,000 | -38.4% | 4,600 | -75.8% | 0.00% | -40.0% |
Q3 2016 | $263,000 | +39.9% | 19,000 | 0.0% | 0.01% | +25.0% |
Q2 2016 | $188,000 | -41.4% | 19,000 | 0.0% | 0.00% | -33.3% |
Q1 2016 | $321,000 | -24.1% | 19,000 | 0.0% | 0.01% | -14.3% |
Q4 2015 | $423,000 | +122.6% | 19,000 | +136.3% | 0.01% | +133.3% |
Q3 2015 | $190,000 | -85.3% | 8,040 | -49.1% | 0.00% | -66.7% |
Q2 2015 | $1,292,000 | – | 15,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |